secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED THERAPEUTICS Corp (UTHR)
CIK:        0001082554
Form:       8-K
Filed at:   2024-03-25T23:59:59+00:00
Accession:  0001104659-24-038478
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United Therapeutics authorizes $1B accelerated share repurchase with Citibank
-----------------------------------------------------------------------------

- Board authorized up to $1B of common stock repurchase; ASR agreement signed with Citibank.
- Initial delivery of ~3,275,199 shares (80% of estimated total) on March 27, 2024.
- Final settlement to occur in Q2 ($300M) and Q3 2024 ($700M) based on VWAP.
- Company also plans $400M credit facility paydown in 2024; $100M already paid in Q1.
- CEO cites balance sheet strength and confidence in near-term prospects for buyback.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1082554/000110465924038478/0001104659-24-038478-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1082554/000110465924038478/tm249556d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-038478

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer